Sunil Badve, MD
Anatomic Pathology & Clinical Pathology · Indianapolis, INNPI 1699732453
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $149,620 of the $219,773 with a category attached, or 68.1%. 11 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 48.0% of the total. Reporting peaked in 2023 at $91,856 and has fallen 93.5% since, to $5,981 in 2025. Among anatomic pathology & clinical pathology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 116 payments — averaging $1894.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$106K
- Agilent Technologies, Inc.$29K
- AstraZeneca$25K
- Ventana Medical Systems, Inc.$20K
- Astrazeneca UK Limited$14K
- Daiichi Sankyo Inc.$13K
- plus $14K from 5 others
Across 8 payments — averaging $12,027 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GE HealthCare$75K
- Caris MPI, Inc.$19K
- F. Hoffmann-la Roche AG$2K
What the payments were for
- Consulting fees$149,62068%
- Speaking & faculty fees$53,84324%
- Travel & lodging$14,0426%
- Food & beverage$2,2691%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 21 | $105,575 |
| Agilent Technologies, Inc. | 42 | $29,186 |
| AstraZeneca | 21 | $24,517 |
| Ventana Medical Systems, Inc. | 5 | $19,700 |
| Astrazeneca UK Limited | 4 | $14,185 |
| Daiichi Sankyo Inc. | 12 | $12,977 |
| Merck | 6 | $10,585 |
| Roche Diagnostics Corporation | 2 | $2,352 |
| Eli Lilly | 1 | $600 |
| Genentech USA, Inc. | 1 | $56 |
| Caris MPI, Inc. | 1 | $39 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Enhertu$21,294
- BENCHMARK IHC/ISH PLATFORMS & REAGENTS$16,200
- OPDIVO$8,904
- PD-L1 IHC 28-8 pharmDx$4,500
- KEYTRUDA$3,965
- INFORM HER2 Dual ISH DNA Probe Cocktail$2,000
- VENTANA PD-L1 (SP263) Assay$1,500
- IMFINZI$537
- PATHWAY anti-HER-2/neu (4B5) Rabbit Monoclonal Primary Antibody$125
How this compares
$219,773 in reported general payments places this provider in the 95th percentile of 137 anatomic pathology & clinical pathology providers in Indiana.
See all anatomic pathology & clinical pathology providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology & clinical pathology in Indianapolis
- Oscar CummingsIndianapolis$75K
- Michael FeldmanIndianapolis$64K
- Romil SaxenaIndianapolis$21K
- Ahmed AlomariIndianapolis$18K
- Michelle ZimmermanIndianapolis$2K
- Mohamed MustafaIndianapolis$1K
- Manan PatelIndianapolis$826
- Bruce HughesIndianapolis$450
- Shanxiang ZhangIndianapolis$335
- Theodore KiefferIndianapolis$273
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.